4//SEC Filing
Sitar Edward J 4
Accession 0001551986-20-000107
CIK 0001551986other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 5:59 PM ET
Size
11.1 KB
Accession
0001551986-20-000107
Insider Transaction Report
Form 4
Sitar Edward J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-30+125,000→ 125,000 totalExercise: $0.70Exp: 2020-04-30→ Common stock (125,000 underlying) - Award
Stock Option (Right to Buy)
2020-04-24+176,156→ 176,156 totalExercise: $0.60From: 2020-04-24Exp: 2030-04-24→ Common stock (176,156 underlying)
Footnotes (2)
- [F1]The option vested in full on 4/24/2020.
- [F2]25% of the option will be deemed vested and exercisable on 4/30/2020, with the remainder vesting monthly over the next 48 months, subject to the executive's continued service with the Company through each applicable vesting date.
Issuer
INNOVATE BIOPHARMACEUTICALS, INC.
CIK 0001551986
Entity typeother
Related Parties
1- filerCIK 0001603489
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 5:59 PM ET
- Size
- 11.1 KB